Press Releases and Media Coverage

2020-03/19
San Miguel County orders residents to shelter in place before countywide coronavirus testing
1
2019-11/26
United BioPharma Signs clinical trial agreement with NIH/NIAID for sponsorship of a multi-drug resistant HIV trial with UB-421
2
2019-11/08
United BioPharma Receives US FDA Approval for UB-221 Phase 1 IND for Chronic Spontaneous Urticaria
3
2019-10/23
In shocking reversal, Biogen to submit experimental Alzheimer’s drug for approval
4
2019-10/07
PharmaBoardRoom interview of Dr. Chang Yi Wang, Chairperson and Chief Scientific Officer of United Biopharma (UBP)
5
2019-09/25
UBI Asia announces IND acceptance by TFDA to conduct the first-in-human (FIH) phase-I trial in adults allergic rhinitis patients for UB-211, an UBITh® Allergy Immunotherapeutic Vaccine
6
2019-07/20
A vaccine for Alzheimer’s is on the verge of becoming a reality
7
2019-06/06
Is an Alzheimer’s Cure on the Horizon?
8
2019-06/11
United BioPharma Receives US FDA Approval for UB-621 Phase 2 Trial in Recurrent Genital Herpes Patients
9
2020-03/19
San Miguel County orders residents to shelter in place before countywide coronavirus testing
1
2019-11/26
United BioPharma Signs clinical trial agreement with NIH/NIAID for sponsorship of a multi-drug resistant HIV trial with UB-421
2
2019-11/08
United BioPharma Receives US FDA Approval for UB-221 Phase 1 IND for Chronic Spontaneous Urticaria
3
2019-10/23
In shocking reversal, Biogen to submit experimental Alzheimer’s drug for approval
4
2019-10/07
PharmaBoardRoom interview of Dr. Chang Yi Wang, Chairperson and Chief Scientific Officer of United Biopharma (UBP)
5
2019-09/25
UBI Asia announces IND acceptance by TFDA to conduct the first-in-human (FIH) phase-I trial in adults allergic rhinitis patients for UB-211, an UBITh® Allergy Immunotherapeutic Vaccine
6
2019-07/20
A vaccine for Alzheimer’s is on the verge of becoming a reality
7
2019-06/06
Is an Alzheimer’s Cure on the Horizon?
8
2019-06/11
United BioPharma Receives US FDA Approval for UB-621 Phase 2 Trial in Recurrent Genital Herpes Patients
9
United BioPharma received approval for UB-421 Phase II clinical trial for HAART substitution treatment in treatment stabilized HIV patients from Taiwan Food and Drug Administration (TFDA) 2015-06/15
Filed an IND submission of a phase II clinical trial for HAART substitution therapy in treatment stabilized HIV patients with Taiwan Food and Drug Administration (TFDA) 2015-02/15
UB-421 product received Gold Medal award for 2014 Pharmaceutical Technology Research and Development jointly given by Ministry of Economic Affairs and Minitry of Health, Taiwan 2014-12/15
Filed an IND submission of a phase I clinical trial for UB-621, an anti-HSV-gD antibody, with Taiwan Food and Drug Administration (TFDA) 2014-12/15
United BioPharma Licenses Innovative Antibody Drug 8D6 for Asthma and Allergy Treatment from Academia Sinica 2014-12/14
Completion of phase IIa clinical trial of UB-421, the anti-CD4 antibody for treatment in HIV treatment naïve patients 2014-11/15
United BioPharma was selected as the recipient by government’s Industrial Cooperation Program (ICP) to carry out the technology transfer of Single Use Disposal system in biological manufacturing from GE Healthcare 2014-09/15
anti-CD4 mAb drug candidate UB-421 won the Gold Medal Prize for Innovative Research and Development given by Taipei City government for 2014 Taipei Biotechnology Award 2014-09/15
United BioPharma was listed on the Taiwan Emerging Stock Market (Stock code : 6471) 2014-09/13
Establishment of UBP’s Clincial Research Center at the Hsinchu Biomedical Science Park 2014-05/15